Our Services

Robust clinical evidence is the bottleneck to adoption.

We help you remove it.

We partner with medical device and healthcare companies to design, execute, and translate clinical evidence into adoption, purchasing decisions, and long-term market positioning.

Engagements are structured around strategic outcomes, not hourly consulting, allowing flexibility based on stage, urgency, and scope.

This work is best suited for:

  • Medical device and health technology companies preparing for clinical validation or scale

  • Teams that seek evidence as the primary driver of adoption

  • Organizations seeking to align clinical, regulatory, and commercial strategy early

  • Founders and executives who want to move beyond “interesting technology” toward real-world utilization

This is likely not the right fit for:

  • Hourly consulting or ad hoc input without execution

  • Short-term marketing rather than clinical validation

  • Zero-investment stages in evidence generation or structured clinical strategy

  • Product concepts lacking a clear clinical use case or pathway to patient impact

Clinical strategy & evidence advisory: Engagement models

Flexible engagement structures

For early-stage or capital-constrained companies, we offer hybrid engagement models that align long-term incentives:

  • Reduced cash retainer in exchange for equity participation

  • Structures tailored to seed and early Series A stages

  • Designed to support companies with strong clinical potential but limited immediate budget

These arrangements are selective and based on strategic alignment, product potential, and ability to generate meaningful clinical impact.

  • Designed for companies preparing to generate or scale clinical evidence to support adoption.

    This includes:

    • Study design and endpoint selection

    • Site strategy and feasibility

    • Clinical workflow alignment

    • Data interpretation and publication strategy

    • Ongoing advisory across trial execution and dissemination

    Typical structure:
    $15,000 – $25,000 per month
    (Longitudinal engagement)

  • Designed for organizations seeking full integration of clinical strategy, evidence generation, and market positioning.

    This expanded model includes:

    • All elements of the Clinical evidence pathway

    • Direct involvement in R&D and product positioning

    • Advisory board development and clinical narrative strategy

    • Integration of real-world evidence and clinician/patient insights (including registry and survey infrastructure)

    Typical structure:
    $30,000 – $40,000 per month
    (High-touch, execution-focused partnership)

  • A focused, short-term engagement to rapidly structure a clinical study or evaluate an existing protocol.

    Includes:

    • Protocol audit and refinement

    • Endpoint optimization

    • Strategic roadmap for execution and dissemination

    Structure:
    $15,000 flat (one-time, 30-day engagement)

Contact us for details